| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/09/2001 | US6172199 Human ubiquitin-conjugating enzyme |
| 01/09/2001 | US6172196 Nucleotide sequences which express polypeptides useful in the production of alcholic beverages and baked goods |
| 01/09/2001 | US6172194 ARF-p19, a novel regulator of the mammalian cell cycle |
| 01/09/2001 | US6172193 Escape mutant of the surface antigen of hepatitis B virus |
| 01/09/2001 | US6172192 Polypeptide or peptide associated microorganism infection; for diagnosis and prevention protozoan infection of mammals |
| 01/09/2001 | US6172188 Fluorescent proteins |
| 01/09/2001 | US6172187 Mammalian polypeptide associated with immune response; for the modulation of apoptosis |
| 01/09/2001 | US6172186 Pseudorabies virus protein |
| 01/09/2001 | US6172184 Genetically engineered protein; for generating disease resistance plants and to amplify plant propagation; for biological pest control |
| 01/09/2001 | US6172049 Supplying macromolecules to cells |
| 01/09/2001 | US6172048 Composition containing nucleic acids, preparation and uses |
| 01/09/2001 | US6172047 Therapy for nervous system tumors |
| 01/09/2001 | US6172042 Synthetic peptides that inhibit IL-6 activity |
| 01/09/2001 | US6172039 Expression of recombinant hemoglobin and hemoglobin variants in yeast |
| 01/09/2001 | US6171864 Nucleotide sequences coding calcium binding protein; for generation of disease and insect resistant plants |
| 01/09/2001 | US6171863 Administering dna-dequalinium complex to cell; gene therapy |
| 01/09/2001 | US6171862 Adding vsv-g protein and polybrene to nucleic acid-lipid complex; genetic engineering |
| 01/09/2001 | US6171861 Recombinational cloning using engineered recombination sites |
| 01/09/2001 | US6171860 Oligonucleotides which target untranslated regions and start codons to prevent transcription of a gene; for treatment of bone disorders, inflammation and cancer; antiinflammatory agents; anticarcinogenic agents; antitumor agents |
| 01/09/2001 | US6171855 Adenoviral expression cassettes which express heterologous gene products; for gene therapy |
| 01/09/2001 | US6171854 Yellow fever infectious cDNA and plasmids |
| 01/09/2001 | US6171846 Culturing cells which are blocked in the synthesis of virginimycins; mutating genes in target microorganism and recovering cells with mutated target genes |
| 01/09/2001 | US6171845 Mutant E. coli kiz strains for production of pantothenic acid |
| 01/09/2001 | US6171842 Chimeric serine proteases |
| 01/09/2001 | US6171841 DNA coding for serine/threonine kinase |
| 01/09/2001 | US6171840 LacC from streptococcus pneumoniae |
| 01/09/2001 | US6171839 Soybean glutathione-S-transferase enzymes |
| 01/09/2001 | US6171838 ratB |
| 01/09/2001 | US6171836 Expression cassette including regulatory sequences and heterologous dna encoding two or more enzymes from metabolic pathway for bioconverstion of cholesterol to hydrocortisone; for recombinant production |
| 01/09/2001 | US6171835 ribH |
| 01/09/2001 | US6171834 Muri protein from Streptococcus pneumoniae |
| 01/09/2001 | US6171828 Efficient recombinant production of proteins by culturing microorganisms having expression unit including target gene linked to promoter activated by methanol and adding methanol periodically or continuously at a determined rate |
| 01/09/2001 | US6171827 Procollagens |
| 01/09/2001 | US6171826 Methods of controlling beta dimer formation in hemoglobin |
| 01/09/2001 | US6171823 Transforming bacteria having cell membranes with recombinant vector encoding a fusion protein of n-terminal prepropeptide of acrhomobacter lyticus protease i fused to desired protein, culturing, and recovering proteins |
| 01/09/2001 | US6171821 Screening for compounds which modulate cap-independent protein translation by exposing x-linked inhibitor of apoptosis internal ribosome entry site reporter cistron with test compound and determining change in amount of translation |
| 01/09/2001 | US6171820 Saturation mutagenesis in directed evolution |
| 01/09/2001 | US6171819 Acyl transfer with stabilized transition complex using catalyst with catalytic imidazole (e.g. histidine) function |
| 01/09/2001 | US6171818 Amino acid sequence of polypeptide from aplysia punctata, a sea snail; for recombinant production of anticarcinogenic agents |
| 01/09/2001 | US6171817 Heterologous polypeptides expressed in filamentous fungi, process for making same, and vectors for making same |
| 01/09/2001 | US6171815 Human sulfonylurea receptor |
| 01/09/2001 | US6171814 Process to increase the production of clavam antibiotics |
| 01/09/2001 | US6171808 Mutant luciferases |
| 01/09/2001 | US6171806 Isolated peptide defined by SEQ ID NO: 17 and uses thereof |
| 01/09/2001 | US6171805 Immunoassay diagnosis of periodontal disease by contacting serum sample with cell surface polypeptide of defined amino acid sequence and detecting antibodies which bind to polypeptide |
| 01/09/2001 | US6171803 Drug screening for allergy treatments by engineering expression of alpha, beta, and gamma subunits of receptor in host cell, incubating with candidate inhibitor, and analyzing for cell expression or cell activation |
| 01/09/2001 | US6171798 Diagnosing cancer or determining p53 status in a sample by comparing level of expression of specific genes to control; lower level indicates cancer |
| 01/09/2001 | US6171795 Nucleic acid ligands to CD40ligand |
| 01/09/2001 | US6171792 Detection systems for registering protein interactions and functional relationships |
| 01/09/2001 | US6171790 Human protease associated proteins |
| 01/09/2001 | US6171789 Nucleotide sequence |
| 01/09/2001 | US6171788 Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
| 01/09/2001 | US6171787 Detecting polynucleotide of tumor necrosis factor-gamma in sample by contacting with polynucleotide of defined nucleotide sequence and determining binding/hybridization; diagnosis of inflammation and related disorders |
| 01/09/2001 | US6171785 Methods and devices for hemogeneous nucleic acid amplification and detector |
| 01/09/2001 | US6171784 Process for typing of HCV isolates |
| 01/09/2001 | US6171783 Detecting parainfluenza virus-3 and respiratory syncytial virus infection by using fusion protein of antigenic proteins from both viruses |
| 01/09/2001 | US6171781 NF-AT polypeptides and polynucleotides |
| 01/09/2001 | US6171612 Gene therapy |
| 01/09/2001 | US6171598 GTP cyclohydrolase II (RIBA) |
| 01/09/2001 | US6171597 Adeno-associated virus vector for boosting immunogenicity of freshly isolated tumor cells |
| 01/09/2001 | US6171592 Equine rhinovirus 1 proteins |
| 01/09/2001 | US6171591 Recombinant nodavirus compositions and methods |
| 01/09/2001 | US6171588 Anti-αvβ3 integrin antibody antagonists |
| 01/09/2001 | US6171587 Antibodies to tissue factor inhibitor |
| 01/09/2001 | US6171584 Method of treatment with growth/differentiation factors of the TGF-β family |
| 01/09/2001 | CA2204640C Conjugates of bdnf and nt-3 with a water-soluble polymer |
| 01/09/2001 | CA2192079C Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
| 01/09/2001 | CA2159101C Use of tomato e8-derived promoters to express s-adenosylmethionine hydrolase in ripening fruit |
| 01/09/2001 | CA2082842C Nucleic acid target generation |
| 01/08/2001 | CA2274880A1 Icam-6 materials and methods |
| 01/07/2001 | CA2310890A1 L-lysine-producing corynebacteria and process for the preparation of l-lysine |
| 01/07/2001 | CA2310870A1 L-lysine-producing corynebacteria and process for the preparation of l-lysine |
| 01/04/2001 | WO2001001218A2 Methods for obtaining and using haplotype data |
| 01/04/2001 | WO2001001143A2 Attachment of biomolecule to a polymeric solid support by cycloaddition of a linker |
| 01/04/2001 | WO2001001137A1 Fusion protein and uses thereof |
| 01/04/2001 | WO2001000881A1 Antisense modulation of pi3k p85 expression |
| 01/04/2001 | WO2001000880A2 Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype |
| 01/04/2001 | WO2001000879A1 Novel kinases and uses thereof |
| 01/04/2001 | WO2001000878A2 A novel vascular endothelial growth factor family member and uses thereof |
| 01/04/2001 | WO2001000877A2 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 01/04/2001 | WO2001000876A1 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 01/04/2001 | WO2001000874A2 Cancer associated antigens and uses therefor |
| 01/04/2001 | WO2001000873A1 ANTISENSE MODULATION OF G-ALPHA-i2 EXPRESSION |
| 01/04/2001 | WO2001000872A1 Antisense modulation of beta catenin expression |
| 01/04/2001 | WO2001000870A2 Method for comparing expression patterns of genes |
| 01/04/2001 | WO2001000869A2 Arrays of catalytic or pre-catalytic nucleic acids |
| 01/04/2001 | WO2001000866A1 An in vivo library-versus-library selection of optimized protein-protein interactions |
| 01/04/2001 | WO2001000864A2 Nucleic acid binding of multi-zinc finger transcription factors |
| 01/04/2001 | WO2001000861A1 Antisense modulation of g-alpha-s1 expression |
| 01/04/2001 | WO2001000860A2 Prolactin-inducible mammary specific promoter |
| 01/04/2001 | WO2001000859A1 Method of inducing angiogenesis by micro-organs |
| 01/04/2001 | WO2001000858A1 Dna sequences specific to rice centromeres |
| 01/04/2001 | WO2001000857A1 Delivery system |
| 01/04/2001 | WO2001000856A1 High efficiency transfection based on low electric field strength, long pulse length |
| 01/04/2001 | WO2001000855A1 Fusion proteins incorporating lysozyme |
| 01/04/2001 | WO2001000853A1 High specificity homocysteinases |
| 01/04/2001 | WO2001000852A1 Regulation of carbon assimilation |
| 01/04/2001 | WO2001000851A1 Cyclic amp phosphodiesterase isoforms and methods of use |
| 01/04/2001 | WO2001000850A1 Lytic enzyme |
| 01/04/2001 | WO2001000849A1 Tankyrase2 materials and methods |